1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
sabalis serrulatae extractum
|
160.0 MG | Substance | Wirkstoff (Principe actif) |
|
macrogolum 10'000
|
- | Substance | HNIDK |
|
gelatina
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | HNIDK |
|
E 132
|
- | Substance | HNIDK |
|
E 172 (flavum)
|
- | Substance | HNIDK |
Authorization holder
Pierre Fabre Pharma SA
4052 Basel
Authorization information
- Swissmedic authorization number
- 52759
- Drug name
- Permixon, Kapseln
- Galenic form
- KAHA
- ATC Code
- G04CX02
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 21/04/1995
- Authorization expiration date
- 31/12/9999
- IT Number
- 05.98.0.
- Domain
- Human medicine
Package details
- Description (FR)
- PERMIXON caps 160 mg 30 pce
- Description (DE)
- PERMIXON Kaps 160 mg 30 Stk
- Market launch
- 21/04/1995
- Narcotic (BTM)
- No
Other package sizes (2)
PERMIXON caps 160 mg 60 pce
60 KAP
GTIN: 7680527590210
None
120 KAP
GTIN: None